Paid-members only

Markets Featured

Why the Best Freight Business of 2026 Flies at 35,000 Feet

Missile strikes deleted 12% of the world's air cargo capacity overnight — and handed airlines' forgotten cargo divisions Covid-era pricing the equity market refuses to value. The boom is real. So is the clock.

Paid-members only

Markets Featured

Top 10 Stocks to Watch: Monday, July 27

Earnings week opens with the AI-power complex bouncing off a brutal Friday and a megacap gauntlet ahead. Ten names on our buy-side radar today, from Bloom and Celestica into their prints to the one Microsoft number that sets the ceiling for the whole trade.

Members only

Markets Featured

10 Stocks Worth Watching This Week: AI Capex on Trial and $100 Oil — July 27–31, 2026

Three central banks, four mega-cap earnings prints, and Brent above $100 — this week decides whether the AI trade stabilizes or the selloff deepens. Ten names positioned for what comes next.

Macro Featured

America's Parents Are Shopping Scared

Back-to-school spending is forecast to hit a record $147 billion — and nearly every number underneath shows a consumer in retreat. The year's first mandatory purchase has become a stress test, and it's flashing a warning for the holiday quarter.

Paid-members only

Markets Featured

Hospitals Spent 20 Years Buying Doctors' Offices. Medicare Just Broke the Math.

Medicare's proposed 2027 outpatient rule guts the two markups that built the modern hospital conglomerate — the facility fee and the 340B drug spread. Budget neutrality means the money doesn't vanish; it moves. Here's who collects.

Paid-members only

Space Economy Featured

Why Are 1990s Satellite Flops Suddenly Worth Billions?

Iridium and Globalstar were the defining bankruptcies of the dot-com era. Ten months and $37 billion later, they anchor Big Tech's land grab for the airwaves between space and your phone — and the FCC just turned those licenses into moats.

Paid-members only

Finance Featured

Bloom Energy (BE) Reports Tuesday. To Reach Even the Low End of Guidance, It Has to Beat Its Best Quarter Ever, Three Times Running.

Bloom Energy fell 14.9% on Friday and sits 47% below its high, yet still trades near 15 times revenue at a company that has never closed a profitable year. Tuesday's print is not really about the quarter. It is about the arithmetic of the back half.

Paid-members only

Markets Featured

Why Is the Strait of Hormuz Still Empty?

The US-Iran ceasefire is five weeks old, yet only 10 tankers a day transit a strait that used to see 130 — and war-risk premiums are rising, not falling. The physical market is pricing a structural premium the equity market refuses to believe.

Macro Featured

Why the Lowest Layoffs Since 1969 Are Bad News

Jobless claims just fell to 187,000 — the fewest since 1969. It isn't strength. The labor market has frozen solid: nobody fired, nobody hired, nobody quitting — and the bill lands on wages, new graduates, and the consumer economy.

Paid-members only

Markets Featured

Whose Money Is Holding Up the Peso?

Argentina just posted record $49.5 billion reserves in the same month the peso hit its weakest level ever. Most of that money is borrowed — and the second half of 2026 tests whether the best EM trade of the decade survives its own plumbing.

Paid-members only

Geopolitics Featured

Europe Froze Russia's Reserves. The Blowback Is Landing in Brussels.

€190 billion of Russian money sits in one Brussels vault. The fight over whether to spend it has quietly become a solvency-and-credibility crisis for Euroclear — and a live repricing of what it costs the world to keep its reserves in the West.

Infrastructure Featured

America's Most Expensive Storms Don't Have Names

Hurricanes get the headlines. But hail and thunderstorms in the middle of the country now cost insurers more than any other disaster — and they're quietly repricing homeownership from Texas to North Dakota.

Finance Featured

Who Pays for a Cure That Only Happens Once?

Biotech cracked the science of curing genetic disease in a single dose. America's insurance system, built to pay for drugs by the month, can't handle a $3 million bill that arrives once — and that mismatch, not the biology, is now the real constraint on the cure economy.

Paid-members only

Markets Featured

Top 10 Stocks to Watch — Friday, July 24: An Oil Shock Meets an AI-Spending Scare

Ten long setups for a rotation day: crude has ripped 36% on the Red Sea, tech is unwinding on AI-capex fear, and a wall of Friday earnings hits before the bell. The catalysts, the pre-market levels, and the triggers we're watching.

Members only

Markets Featured

How Three Companies Won the Streaming Wars — by Rebuilding Cable

The cord-cutting era promised cheaper, unbundled, ad-free TV. It ended in an oligopoly. Netflix and Disney own the pricing power; Paramount Skydance bought Warner to force its way into the third seat. Here's who won — and how to trade a war that's already over.

Paid-members only

Finance Featured

Nvidia Just Prepaid Amkor (AMKR) $1.5 Billion for AI Packaging — Three Days Before Earnings. Here's What Monday Has to Prove.

Nvidia's $1.5B prepayment neutralized Amkor's biggest bear thesis and re-rated an OSAT into an AI stock overnight. But the revenue doesn't hit the P&L until 2028 — and Q2 earnings land Monday. The prepayment mechanics and three scenario price zones.

Paid-members only

Finance Featured

Japan's Bond Market Is 60 Basis Points From a Forced-Selling Spiral

Japan's life insurers were the structural backstop for the world's most important suppressed-rate market. They just flipped to sellers — and a single yield level near 4.5% turns their selling reflexive.

Paid-members only

Finance Featured

The Last Trophy Asset Just Went Institutional

Private equity spent eighteen months buying into NFL, NBA, and MLB franchises. Then KKR paid $1.4 billion for the firm doing the buying. The trophy is now an asset class — and the alpha has already moved.

Healthcare Featured

America Is About to Tariff Its Own Medicine Cabinet

On July 31, Trump's Section 232 tariffs hit the world's most globalized supply chain. Big Pharma bought its way out with $480B in pledges. The generic industry — 90% of America's prescriptions — can't.

Paid-members only

Markets Featured

Top 10 Stocks to Watch — Thursday, July 23: Capex on Trial

The deepest day of Q2 earnings puts one question on trial: is the spending working? Alphabet and Tesla fall on capex, the defense primes beat and raise, copper prints a record, and Intel answers tonight. Ten names to watch, ranked by catalyst.

Paid-members only

Markets Featured

Cleveland-Cliffs (CLF) Just Guided Q3 EBITDA to Double on a $5.2 Billion Quarter. The Stock Is a Levered Bet on One Number. Here's the Distribution.

Cleveland-Cliffs jumped 9% on a quarter where it still lost money — because for a $7.7B-levered, 2.13-beta steelmaker, the Q3 guide to double EBITDA is the whole trade. The leverage math, the EBITDA bridge, and three scenario price zones.

Paid-members only

Markets Featured

Top 10 Stocks to Watch — Wednesday, July 22: Big Tech Earnings Night

Alphabet, Tesla, Texas Instruments, and IBM all report after the close tonight — while Super Micro's $60B AI backlog and rising oil set the premarket tone. The ten names we're watching into the open, ranked by catalyst.

Macro Featured

For the First Time in Fifty Years, the New House Is the Cheap One

For the first time in five decades, a new home is cheaper than an existing one. Builder rate-buydowns engineered the discount; rate-locked boomers froze the resale market. The inversion nobody outside the industry is watching.

Paid-members only

Space Economy Featured

Low Earth Orbit Just Got Too Expensive to Insure

The CRASH clock fell from 121 days to five. As LEO fills with 54,000 tracked objects, the space insurance market is repricing faster than the satellites can adapt — and the money is moving to whoever can track the traffic.

Paid-members only

Geopolitics Featured

America Is Racing a November Deadline for the Metal Behind Every Bullet

China's ban on antimony, gallium, and germanium was lifted only until November 27, 2026. The race to reshore the metal behind every bullet is one of the year's most under-priced trades.